by Jordana Choucair | Jun 15, 2022 | Public Health/Prevention
The Biden administration plans to unveil a National Biodefense Strategy that will outline preparedness, response, and recovery protocols against biothreats. According to people familiar with the matter, the framework could be released this month, along with a request...
by Jordana Choucair | Jun 14, 2022 | Providers
The American Medical Association (AMA) voted in favor of resolutions that oppose state-level measures to criminalize abortion and other reproductive care services. The AMA also backed the availability of the medication abortion drug mifepristone and said it would...
by Jordana Choucair | Jun 14, 2022 | Inequities and SDOH
Bank of America announced it is committing $40 million to develop community health centers and other primary care facilities in medically underserved areas as part of ongoing racial equality efforts. The new funding builds on the company’s recent $25 million...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
Senator Amy Klobuchar and Representative Katie Porter asked the Federal Trade Commission (FTC) to investigate whether Janssen Pharmaceuticals and Bristol Myers Squibb Co. coordinated “parallel” price increases on Xarelto and Eliquis. The letter noted that,...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first treatment for alopecia treatment that restores hair growth. The agency said that two trials showed that Eli Lilly & Co.’s Olumiant helped roughly 40 percent of the 1,2000 trial participants achieve...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
An amendment to the Senate’s latest FDA user fee proposal calls on infant formula manufacturers to notify the agency within five business days of a disruption to their supply chain, an attempt to better guard against future formula shortages. The amendment...
Recent Comments